| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | SVP &General Counsel
1 company
Wilson Mark Andrew is a Chief Legal Officer at NEKTAR THERAPEUTICS. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $1.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2021 | NKTR Nektar Therapeutics | SVP &General Counsel | Sell | 2,173 | $22.37 | $48,610.01 | -2.8% | |
| Feb 3, 2021 | NKTR Nektar Therapeutics | SVP &General Counsel | Sale+OE | 5,344 | $19.45 | $103,940.80 | -6.3% | |
| Nov 16, 2020 | NKTR Nektar Therapeutics | SVP &General Counsel | Sell | 1,539 | $16.93 | $26,055.27 | -3.0% | |
| Aug 17, 2020 | NKTR Nektar Therapeutics | SVP &General Counsel | Sell | 1,529 | $19.67 | $30,075.43 | -2.9% | |
| May 18, 2020 | NKTR Nektar Therapeutics | SVP &General Counsel | Sell | 1,529 | $22.51 | $34,417.79 | -2.8% |